Cargando…
Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis
Rifaximin and lactulose are widely used in patients with hepatic encephalopathy (HE); however, data on whether the combined use of rifaximin and lactulose could yield additional benefits for patients with HE are limited and inconclusive. We conducted a systematic review and meta-analysis of randomiz...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041837/ https://www.ncbi.nlm.nih.gov/pubmed/35471992 http://dx.doi.org/10.1371/journal.pone.0267647 |